Why the study?
Hyperinsulinaemia-associated laminitis causes significant morbidity and mortality in horses with equine metabolic syndrome, making its diagnosis and management critical.
What are the current diagnostics, management strategies, and new therapies for hyperinsulinaemia in horses with equine metabolic syndrome?
What are the current diagnostics, management strategies, and new therapies for hyperinsulinaemia in horses with equine metabolic syndrome?
This review provides an overview of diagnostics and management strategies for hyperinsulinaemia in horses with equine metabolic syndrome to prevent laminitis.
May aid equine hyperinsulinaemia management to prevent laminitis; leaves open optimal use of emerging therapies.
Summary Laminitis associated with hyperinsulinaemia is a significant cause of morbidity and mortality in horses with equine metabolic syndrome. The diagnosis and management of hyperinsulinaemia are therefore critical to prevent the development of laminitis. This review article aims to help primary care clinicians manage patients with hyperinsulinaemia by providing an overview of diagnostics, management strategies and new therapies that are available.
No takes yet. Share an insight, caveat, or question.
Sundra et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: